| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10897339 | Cancer Epidemiology | 2014 | 7 Pages |
Abstract
Available HPV vaccines could potentially prevent 77.8% of Bosnian cervical cancer cases (i.e. those associated with HPV16/18). If the reported magnitude of the cross-protection of licensed vaccines for non-vaccine HPV types is long lasting, an additional 6 to 10% of cases could be prevented.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Ermina IljazoviÄ, Marisa Mena, Sara Tous, Laia Alemany, FeÄa OmeragiÄ, Azra SadikoviÄ, Omar Clavero, Marleny Vergara, F. Xavier Bosch, Silvia de Sanjosé,